726 related articles for article (PubMed ID: 31881765)
1. Antioxidative and Anti-Inflammatory Properties of Cannabidiol.
Atalay S; Jarocka-Karpowicz I; Skrzydlewska E
Antioxidants (Basel); 2019 Dec; 9(1):. PubMed ID: 31881765
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G
Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286
[TBL] [Abstract][Full Text] [Related]
3. Synthetic and Natural Derivatives of Cannabidiol.
Morales P; Jagerovic N
Adv Exp Med Biol; 2021; 1297():11-25. PubMed ID: 33537934
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol: State of the art and new challenges for therapeutic applications.
Pisanti S; Malfitano AM; Ciaglia E; Lamberti A; Ranieri R; Cuomo G; Abate M; Faggiana G; Proto MC; Fiore D; Laezza C; Bifulco M
Pharmacol Ther; 2017 Jul; 175():133-150. PubMed ID: 28232276
[TBL] [Abstract][Full Text] [Related]
5. A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol.
Sunda F; Arowolo A
FASEB J; 2020 Nov; 34(11):14083-14092. PubMed ID: 32885502
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer's Disease.
Hickey JP; Collins AE; Nelson ML; Chen H; Kalisch BE
Curr Issues Mol Biol; 2024 May; 46(5):4379-4402. PubMed ID: 38785534
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.
Yousaf M; Chang D; Liu Y; Liu T; Zhou X
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956911
[TBL] [Abstract][Full Text] [Related]
8.
Kopustinskiene DM; Masteikova R; Lazauskas R; Bernatoniene J
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453344
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol protects keratinocyte cell membranes following exposure to UVB and hydrogen peroxide.
Atalay S; Dobrzyńska I; Gęgotek A; Skrzydlewska E
Redox Biol; 2020 Sep; 36():101613. PubMed ID: 32863232
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.
Melas PA; Scherma M; Fratta W; Cifani C; Fadda P
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668469
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors.
Sonego AB; Prado DS; Vale GT; Sepulveda-Diaz JE; Cunha TM; Tirapelli CR; Del Bel EA; Raisman-Vozari R; Guimarães FS
Brain Behav Immun; 2018 Nov; 74():241-251. PubMed ID: 30217539
[TBL] [Abstract][Full Text] [Related]
13. A Novel Standardized
Mabou Tagne A; Marino F; Legnaro M; Luini A; Pacchetti B; Cosentino M
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013912
[TBL] [Abstract][Full Text] [Related]
14. From
Cassano T; Villani R; Pace L; Carbone A; Bukke VN; Orkisz S; Avolio C; Serviddio G
Front Pharmacol; 2020; 11():124. PubMed ID: 32210795
[No Abstract] [Full Text] [Related]
15. Oxidative Stress and Multi-Organel Damage Induced by Two Novel Phytocannabinoids, CBDB and CBDP, in Breast Cancer Cells.
Salbini M; Quarta A; Russo F; Giudetti AM; Citti C; Cannazza G; Gigli G; Vergara D; Gaballo A
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577048
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.
Hayakawa K; Mishima K; Fujiwara M
Pharmaceuticals (Basel); 2010 Jul; 3(7):2197-2212. PubMed ID: 27713349
[TBL] [Abstract][Full Text] [Related]
17. Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.
Kozela E; Juknat A; Gao F; Kaushansky N; Coppola G; Vogel Z
J Neuroinflammation; 2016 Jun; 13(1):136. PubMed ID: 27256343
[TBL] [Abstract][Full Text] [Related]
18. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
Fride E; Ponde D; Breuer A; Hanus L
Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol for neurodegenerative disorders: A comprehensive review.
Bhunia S; Kolishetti N; Arias AY; Vashist A; Nair M
Front Pharmacol; 2022; 13():989717. PubMed ID: 36386183
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris.
Pagano C; Ciaglia E; Coppola L; Lopardo V; Raimondo A; Giuseppe M; Lembo S; Laezza C; Bifulco M
Front Immunol; 2024; 15():1373435. PubMed ID: 38601151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
